Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients
- PMID: 39945009
- PMCID: PMC12358778
- DOI: 10.3324/haematol.2024.285788
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients
References
-
- Christ TN, Stock W, Knoebel RW. Incidence of asparaginaserelated hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen. J Oncol Pharm Pract. 2018;24(4):299-308. - PubMed
-
- Buhtoiarov IN, Zembillas AS. Excessive toxicities of pegylated asparaginase in pediatric acute lymphoblastic leukemia patients with high body surface area: a call for action. Pediatr Blood Cancer. 2021;68(3):e28743. - PubMed
LinkOut - more resources
Full Text Sources
